Drreddys Laboratories | RDY - Passivo Circulante





Passivo Circulante Alterar Data
ANI Pharmaceuticals USD 283.65M 44.14M 2026-06
Aurora Cannabis CAD 66.93M 79M 2026-03
Bayer EUR 32.27B 1.19B 2026-06
Canopy Growth CAD 158.44M 60.15M 2026-03
Cipla INR 70.14B 7.16B 2026-03
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Drreddys Laboratories INR 167.57B 165.8B 2026-03
GlaxoSmithKline GBP 21.53B 895M 2026-06
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lonza CHF 3.57B 421M 2025-12
Novartis USD 31.75B 374M 2026-06
Pacira USD 122.01M 13.22M 2026-06
Phibro Animal Health USD 316.47M 34.6M 2026-06
Prestige Brands USD 153.81M 32.88M 2026-06
Richter Gedeon HUF 179.31B 8.13B 2026-03
Sun Pharmaceuticals INR 226.22B 7.93B 2026-03
Supernus Pharmaceuticals USD 347.38M 26.55M 2026-06
Teva Pharmaceutical Industries USD 15.65B 2.11B 2026-06